Willmann, Gabriel. Ultraviolet keratitis: From the pathophysiological basis to prevention and clinical management. High Alt Med Biol 16:277–282, 2015.—Ultraviolet keratitis is caused by the toxic effects of acute high-dose ultraviolet radiation (UVR) reflecting the sensitivity of the ocular surface to photochemical injury. The clinical syndrome presents with ocular pain, tearing, conjunctival chemosis, blepharospasm, and deterioration of vision typically several hours after exposure, lasting up to 3 days. Mountaineers, skiers, and beach recreationalists are particularly at risk to suffer from ultraviolet (UV) keratitis as the reflectivity of UVR in these environments is extremely high. The aim of this review is to raise awareness about the potential of UV damage on the eye with an emphasis on UV keratitis, to highlight the pathophysiological basis of corneal phototoxicity, and to provide practical guidance for the prevention and clinical management of UV keratitis commonly known as snow blindness.
Get full access to this article
View all access options for this article.
References
1.
AnsteyA, TaylorD, ChalmersI, and AnsariE. (1999). Ultraviolet radiation-blocking characteristics of contact lenses: Relevance to eye protection for psoralen-sensitised patients. Photodermatol Photoimmunol Photomed, 15:193–197.
2.
AtkinsonSC. (1921). SNOW-BLINDNESS: Its causes, effects, changes, prevention, and treatment. Br J Ophthalmol, 5:49–54.
3.
BachemA. (1956). Ophthalmic ultraviolet action spectra. Am J Ophthalmol, 41:969–975.
4.
BauerIL. (2015). Contact lens wearers' experiences while trekking in the Khumbu region/Nepal: A cross-sectional survey. Travel Med Infect Dis, 13:178–184.
5.
BazzaziN, HeydarianS, VahabiR, AkbarzadehS, and FouladiDF. (2015). Quality of sunglasses available in the Iranian market; a study with emphasis on sellers' license. Indian J Ophthalmol, 63:152–156.
6.
Behar-CohenF, BailletG, de AyguavivesT, GarciaPO, KrutmannJ, Pena-GarciaP, RemeC, and WolffsohnJS. (2014). Ultraviolet damage to the eye revisited: Eye-sun protection factor (E-SPF(R)), a new ultraviolet protection label for eyewear. Clin Ophthalmol, 8:87–104.
7.
BergendiL, BenesL, DurackovaZ, and FerencikM. (1999). Chemistry, physiology and pathology of free radicals. Life Sci, 65:1865–1874.
8.
BlackAT, GordonMK, HeckDE, GalloMA, LaskinDL, and LaskinJD. (2011). UVB light regulates expression of antioxidants and inflammatory mediators in human corneal epithelial cells. Biochem Pharmacol, 81:873–880.
9.
BorgwardtB, FishmanGA, and Vander-MeulenD. (1981). Spectral transmission characteristics of tinted lenses. Arch Ophthalmol, 99:293–297.
10.
BursteinNL. (1980). Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol, 25:15–30.
11.
ButlerFKJr. (1999). The eye at altitude. Int Ophthalmol Clin, 39:59–78.
12.
CaiCX, BirkDE, and LinsenmayerTF. (1998). Nuclear ferritin protects DNA from UV damage in corneal epithelial cells. Mol Biol Cell, 9:1037–1051.
13.
ChaoSC, HuDN, YangPY, LinCY, NienCW, YangSF, and RobertsJE. (2013). Ultraviolet-A irradiation upregulated urokinase-type plasminogen activator in pterygium fibroblasts through ERK and JNK pathways. Invest Ophthalmol Vis Sci, 54:999–1007.
14.
ChenY, ThompsonDC, KoppakaV, JesterJV, and VasiliouV. (2013). Ocular aldehyde dehydrogenases: Protection against ultraviolet damage and maintenance of transparency for vision. Prog Retin Eye Res, 33:28–39.
15.
CoganDG, and KinseyVE. (1946). Action spectrum of keratitis produced by ultraviolet radiation. Arch Ophthal, 35:670–677.
16.
CullenAP. (2002). Photokeratitis and other phototoxic effects on the cornea and conjunctiva. Int J Toxicol, 21:455–464.
17.
DaltonTP, ChenY, SchneiderSN, NebertDW, and ShertzerHG. (2004). Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radic Biol Med, 37:1511–1526.
18.
DeanRT, FuS, StockerR, and DaviesMJ. (1997). Biochemistry and pathology of radical-mediated protein oxidation. Biochem J, 324(Pt 1):1–18.
19.
DolinPJ, and JohnsonGJ. (1994). Solar ultraviolet radiation and ocular disease: A review of the epidemiological and experimental evidence. Ophthalmic Epidemiol, 1:155–164.
20.
EllertonJA, ZuljanI, AgazziG, and BoydJJ. (2009). Eye problems in mountain and remote areas: Prevention and onsite treatment—Official recommendations of the International Commission for Mountain Emergency Medicine ICAR MEDCOM. Wilderness Environ Med, 20:169–175.
21.
EsterbauerH, SchaurRJ, and ZollnerH. (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med, 11:81–128.
22.
EsteyT, PiatigorskyJ, LassenN, and VasiliouV. (2007). ALDH3A1: A corneal crystallin with diverse functions. Exp Eye Res, 84:3–12.
23.
HalliwellB. (1998). Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Problems, resolutions and preliminary results from nutritional supplementation studies. Free Radic Res, 29:469–486.
24.
HerrligkofferKM. (1958). [Protection against snow burn; experiences from two Himalaya expeditions with corodenin, Diwag-light protection ointment and labiosan]. Munch Med Wochenschr, 100:1856–1858.
25.
KolozsvariL, NogradiA, HoppB, and BorZ. (2002). UV absorbance of the human cornea in the 240- to 400-nm range. Invest Ophthalmol Vis Sci, 43:2165–2168.
26.
KwokLS, KuznetsovVA, HoA, and CoroneoMT. (2003). Prevention of the adverse photic effects of peripheral light-focusing using UV-blocking contact lenses. Invest Ophthalmol Vis Sci, 44:1501–1507.
27.
LiraM, Dos Santos CastanheiraEM, SantosL, AzeredoJ, Yebra-PimentelE, and Real OliveiraME. (2009). Changes in UV-visible transmittance of silicone-hydrogel contact lenses induced by wear. Optom Vis Sci, 86:332–339.
28.
LiuZG, BaskaranR, Lea-ChouET, WoodLD, ChenY, KarinM, and WangJY. (1996). Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature, 384:273–276.
29.
MarchittiSA, ChenY, ThompsonDC, and VasiliouV. (2011). Ultraviolet radiation: Cellular antioxidant response and the role of ocular aldehyde dehydrogenase enzymes. Eye Contact Lens, 37:206–213.
30.
McIntoshSE, GuercioB, TabinGC, LeemonD, and SchimelpfenigT. (2011). Ultraviolet keratitis among mountaineers and outdoor recreationalists. Wilderness Environ Med, 22:144–147.
31.
MerriamJC. (1996). The concentration of light in the human lens. Trans Am Ophthalmol Soc, 94:803–918.
32.
MillodotM, and EarlamRA. (1984). Sensitivity of the cornea after exposure to ultraviolet light. Ophthalmic Res, 16:325–328.
33.
NorrenDV, and VosJJ. (1974). Spectral transmission of the human ocular media. Vision Res, 14:1237–1244.
34.
NorvalM, CullenAP, de GruijlFR, LongstrethJ, TakizawaY, LucasRM, NoonanFP, and van der LeunJC. (2007). The effects on human health from stratospheric ozone depletion and its interactions with climate change. Photochem Photobiol Sci, 6:232–251.
35.
PappaA, ChenC, KoutalosY, TownsendAJ, and VasiliouV. (2003). Aldh3a1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage. Free Radic Biol Med, 34:1178–1189.
36.
PatelM, and FraunfelderFW. (2013). Toxicity of topical ophthalmic anesthetics. Expert Opin Drug Metab Toxicol, 9:983–988.
37.
PiatigorskyJ. (2001). Enigma of the abundant water-soluble cytoplasmic proteins of the cornea: The “refracton” hypothesis. Cornea, 20:853–858.
38.
PittsDG, and TrediciTJ. (1971). The effects of ultraviolet on the eye. Am Ind Hyg Assoc J, 32:235–246.
RiegerG. (2001). Anti-oxidative capacity of various artificial tear preparations. Graefes Arch Clin Exp Ophthalmol, 239:222–226.
41.
RosenthalFS, BakalianAE, LouCQ, and TaylorHR. (1988). The effect of sunglasses on ocular exposure to ultraviolet radiation. Am J Public Health, 78:72–74.
42.
SasakiH, SakamotoY, SchniderC, FujitaN, HatsusakaN, SlineyDH, and SasakiK. (2011). UV-B exposure to the eye depending on solar altitude. Eye Contact Lens, 37:191–195.
43.
SlineyDH. (1997). Ocular exposure to environmental light and ultraviolet—The impact of lid opening and sky conditions. Dev Ophthalmol, 27:63–75.
44.
SlineyDH. (1999). Geometrical assessment of ocular exposure to environmental UV radiation—Implications for ophthalmic epidemiology. J Epidemiol, 9:S22–S32.
45.
SlineyDH. (2001). Photoprotection of the eye—UV radiation and sunglasses. J Photochem Photobiol B, 64:166–175.
46.
SlineyDH. (2011). Intraocular and crystalline lens protection from ultraviolet damage. Eye Contact Lens, 37:250–258.
47.
SuiGY, LiuGC, LiuGY, GaoYY, DengY, WangWY, TongSH, and WangL. (2013). Is sunlight exposure a risk factor for age-related macular degeneration? A systematic review and meta-analysis. Br J Ophthalmol, 97:389–394.
48.
SydenhamMM, CollinsMJ, and HirstLW. (1997). Measurement of ultraviolet radiation at the surface of the eye. Invest Ophthalmol Vis Sci, 38:1485–1492.
49.
TangPH, KonoM, KoutalosY, AblonczyZ, and CrouchRK. (2013). New insights into retinoid metabolism and cycling within the retina. Prog Retin Eye Res, 32:48–63.
50.
van NorrenD, and GorgelsTG. (2011). The action spectrum of photochemical damage to the retina: A review of monochromatic threshold data. Photochem Photobiol, 87:747–753.
51.
VelpandianT, RaviAK, KumariSS, BiswasNR, TewariHK, and GhoseS. (2005). Protection from ultraviolet radiation by spectacle lenses available in India: A comparative study. Natl Med J India, 18:242–244.
52.
WaldG. (1945). Human vision and the spectrum. Science, 101:653–658.
53.
WalshJE, and BergmansonJP. (2011). Does the eye benefit from wearing ultraviolet-blocking contact lenses?. Eye Contact Lens, 37:267–272.
54.
WatsonWH, ChenY, and JonesDP. (2003). Redox state of glutathione and thioredoxin in differentiation and apoptosis. Biofactors, 17:307–314.
55.
WillmannG, SchatzA, FischerMD, SchommerK, ZrennerE, Bartz-SchmidtKU, GekelerF, and GekelerK. (2014). Exposure to high altitude alters tear film osmolarity and breakup time. High Alt Med Biol, 15:203–207.
56.
YamJC, and KwokAK. (2014). Ultraviolet light and ocular diseases. Int Ophthalmol, 34:383–400.
57.
ZuclichJA. (1989). Ultraviolet-induced photochemical damage in ocular tissues. Health Phys, 56:671–682.
